Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) issued its earnings results on Wednesday. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01), Zacks reports. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. The firm had revenue of $46.40 million during the quarter, compared to analyst estimates of $47.27 million.
Crescent Capital BDC Stock Down 4.8 %
Shares of NASDAQ CCAP opened at $19.05 on Thursday. Crescent Capital BDC has a 1 year low of $16.38 and a 1 year high of $20.19. The firm has a market cap of $705.99 million, a price-to-earnings ratio of 7.45 and a beta of 0.81. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26. The stock’s 50-day simple moving average is $19.48 and its 200-day simple moving average is $18.86.
Crescent Capital BDC Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.82%. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date was Tuesday, December 31st. Crescent Capital BDC’s payout ratio is presently 65.88%.
Analyst Ratings Changes
Read Our Latest Research Report on CCAP
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Stories
- Five stocks we like better than Crescent Capital BDC
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Should You Hold Nvidia Stock for the Long Haul or Trade It?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
- Consumer Staples Stocks, Explained
- Buybacks Galore: 3 Mega-Caps Just Approved Billions in Buybacks
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.